EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
- Author
- RAO, Zhi-Yue1 ; CAI, Mu-Yan1 ; ZENG, Yi-Xin1 ; KUNG, Hsiang-Fu1 3 ; DAN XIE1 ; YANG, Guo-Fen2 ; HE, Li-Ru1 ; MAI, Shi-Juan1 ; HUA, Wen-Feng1 ; LIAO, Yi-Ji1 ; DENG, Hai-Xia1 ; CHEN, Yang-Chao3 ; GUAN, Xin-Yuan1
[1] The State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, 510060 Guangzhou, China
[2] Department of Gynecology, the First Affiliated Hospital, Sun Yat-Sen University, 510078 Guangzhou, China
[3] The State Key Laboratory of Oncology in South China, the Chinese University of Hong Kong, Hong-Kong - Source
Carcinogenesis (New York. Print). 2010, Vol 31, Num 9, pp 1576-1583, 8 p ; ref : 37 ref
- CODEN
- CRNGDP
- ISSN
- 0143-3334
- Scientific domain
- Medical oncology; Genetics; Pharmacology drugs; Toxicology
- Publisher
- Oxford University Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Cancer de l'ovaire Carcinome de l'ovaire Cellule tumorale Facteur croissance transformant β1 Facteur prédictif Histone-lysine N-methyltransferase Homme Invasion Métastase Pronostic Prédicteur Répresseur transcription Gène Ezh2 Cancer Enzyme Methyltransferases Pathologie de l'appareil génital femelle Pathologie des ovaires Transferases Tumeur maligne
- Keyword (en)
- Ovary cancer Ovary carcinoma Tumor cell Transforming growth factor β1 Predictive factor Histone-lysine N-methyltransferase Human Invasion Metastasis Prognosis Predictor Transcription repressor Ezh2 gene Cancer Enzyme Methyltransferases Female genital diseases Ovarian diseases Transferases Malignant tumor
- Keyword (es)
- Cáncer del ovario Carcinoma de ovario Célula tumoral Factor crecimiento transformante β1 Factor predictivo Histone-lysine N-methyltransferase Hombre Invasión Metástasis Pronóstico Predictor Represor transcripción Cáncer Enzima Methyltransferases Aparato genital hembra patología Ovario patología Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04E Carcinogenesis, carcinogens and anticarcinogens
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20C Female genital diseases / 002B20C02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23195917
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/carcin/bgq150 
https://dx.doi.org/10.1093/carcin/bgq150
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/carcin\/bgq150\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Carcinogenesis (New York. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Carcinogenesis (N. Y., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1576\";s:8:\"\u0000*\u0000epage\";s:4:\"1583\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0143-3334\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"RAO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Zhi-Yue\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:11:\"CAI, Mu-Yan\";i:1;s:12:\"ZENG, Yi-Xin\";i:2;s:15:\"KUNG, Hsiang-Fu\";i:3;s:7:\"DAN XIE\";i:4;s:13:\"YANG, Guo-Fen\";i:5;s:9:\"HE, Li-Ru\";i:6;s:13:\"MAI, Shi-Juan\";i:7;s:13:\"HUA, Wen-Feng\";i:8;s:11:\"LIAO, Yi-Ji\";i:9;s:13:\"DENG, Hai-Xia\";i:10;s:15:\"CHEN, Yang-Chao\";i:11;s:14:\"GUAN, Xin-Yuan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CRNGDP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/carcin\/bgq150\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Carcinogenesis (New York. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Carcinogenesis (N. Y., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1576\";s:8:\"\u0000*\u0000epage\";s:4:\"1583\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0143-3334\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"RAO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Zhi-Yue\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:11:\"CAI, Mu-Yan\";i:1;s:12:\"ZENG, Yi-Xin\";i:2;s:15:\"KUNG, Hsiang-Fu\";i:3;s:7:\"DAN XIE\";i:4;s:13:\"YANG, Guo-Fen\";i:5;s:9:\"HE, Li-Ru\";i:6;s:13:\"MAI, Shi-Juan\";i:7;s:13:\"HUA, Wen-Feng\";i:8;s:11:\"LIAO, Yi-Ji\";i:9;s:13:\"DENG, Hai-Xia\";i:10;s:15:\"CHEN, Yang-Chao\";i:11;s:14:\"GUAN, Xin-Yuan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CRNGDP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/carcin\/bgq150\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/carcin\/bgq150\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Carcinogenesis (New York. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Carcinogenesis (N. Y., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1576\";s:8:\"\u0000*\u0000epage\";s:4:\"1583\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0143-3334\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"RAO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Zhi-Yue\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:11:\"CAI, Mu-Yan\";i:1;s:12:\"ZENG, Yi-Xin\";i:2;s:15:\"KUNG, Hsiang-Fu\";i:3;s:7:\"DAN XIE\";i:4;s:13:\"YANG, Guo-Fen\";i:5;s:9:\"HE, Li-Ru\";i:6;s:13:\"MAI, Shi-Juan\";i:7;s:13:\"HUA, Wen-Feng\";i:8;s:11:\"LIAO, Yi-Ji\";i:9;s:13:\"DENG, Hai-Xia\";i:10;s:15:\"CHEN, Yang-Chao\";i:11;s:14:\"GUAN, Xin-Yuan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CRNGDP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/carcin\/bgq150\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:9:\"\u0000*\u0000jtitle\";s:32:\"Carcinogenesis (New York. Print)\";s:9:\"\u0000*\u0000stitle\";s:29:\"Carcinogenesis (N. Y., Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1576\";s:8:\"\u0000*\u0000epage\";s:4:\"1583\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0143-3334\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"RAO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Zhi-Yue\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:11:\"CAI, Mu-Yan\";i:1;s:12:\"ZENG, Yi-Xin\";i:2;s:15:\"KUNG, Hsiang-Fu\";i:3;s:7:\"DAN XIE\";i:4;s:13:\"YANG, Guo-Fen\";i:5;s:9:\"HE, Li-Ru\";i:6;s:13:\"MAI, Shi-Juan\";i:7;s:13:\"HUA, Wen-Feng\";i:8;s:11:\"LIAO, Yi-Ji\";i:9;s:13:\"DENG, Hai-Xia\";i:10;s:15:\"CHEN, Yang-Chao\";i:11;s:14:\"GUAN, Xin-Yuan\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CRNGDP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:149:\"EZH2 supports ovarian carcinoma cell invasion and\/or metastasis via regulation of TGF-\u03b21 and is a predictor of outcome in ovarian carcinoma patients\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
